Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
04:05pm, Thursday, 14'th Nov 2024
New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences Data showed ability of INO-3107 to induce an antigen-specific cytotoxic T cell respo
New immunology data shows INO-3107 induced an expansion of new clonal T cells in blood that were not detectable prior to treatment New clonal T cells in the blood travelled to papilloma and airway tis
INOVIO to Present at Upcoming Scientific Conferences
04:05pm, Wednesday, 06'th Nov 2024
PLYMOUTH MEETING, Pa. , Nov. 6, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-rela
INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
08:00am, Wednesday, 06'th Nov 2024
PLYMOUTH MEETING, Pa. , Nov. 6, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-as
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
08:00am, Monday, 21'st Oct 2024
American Association for Cancer Research (AACR) Special Conference: Tumor Immunology and Immunotherapy : New immunology data showed ability of INO-3107 to induce an antigen-specific T cell response ag
Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
06:41am, Wednesday, 09'th Oct 2024
Inovio (INO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
INOVIO Reports Inducement Grants Under Inducement Plan
04:15pm, Wednesday, 02'nd Oct 2024
PLYMOUTH MEETING, Pa. , Oct. 2, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
INOVIO to Present at Upcoming Scientific Conferences
08:00am, Tuesday, 01'st Oct 2024
PLYMOUTH MEETING, Pa. , Oct. 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-rela
INOVIO to Present at Upcoming Scientific Conference
04:30pm, Tuesday, 17'th Sep 2024
PLYMOUTH MEETING, Pa. , Sept. 17, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript
03:32am, Friday, 09'th Aug 2024
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacqueline Shea - President & Chi
INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights
04:05pm, Thursday, 08'th Aug 2024
PLYMOUTH MEETING, Pa. , Aug. 8, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-rel
INOVIO Reports Inducement Grant Under Inducement Plan
04:05pm, Thursday, 01'st Aug 2024
PLYMOUTH MEETING, Pa. , Aug. 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
Data reviewed complies with standards that would be used to evaluate an EU Marketing Authorization Application PLYMOUTH MEETING, Pa. , July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechno
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024
08:00am, Thursday, 25'th Jul 2024
PLYMOUTH MEETING, Pa. , July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-as
Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK
11:11am, Friday, 12'th Jul 2024
Inovio (INO) soars 19% as its lead candidate, INO-3107, receives the innovative medicine tag under the U.K.'s Innovative Licensing and Access Pathway to treat recurrent respiratory papillomatosis.
